05.12.2007 22:11:00

Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Genesco Inc.

Coughlin Stoia Geller Rudman & Robbins LLP ("Coughlin Stoia”) (http://www.csgrr.com/cases/genesco/) today announced that a class action has been commenced in the United States District Court for the Middle District of Tennessee on behalf of purchasers of Genesco Inc. ("Genesco”) (NYSE:GCO) common stock during the period between April 20, 2007 and November 26, 2007 (the "Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Darren Robbins of Coughlin Stoia at 800/449-4900 or 619/231-1058, or via e-mail at djr@csgrr.com. If you are a member of this class, you can view a copy of the complaint as filed or join this class action online at http://www.csgrr.com/cases/genesco/. Any member of the purported class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. The complaint charges Genesco and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Genesco is a retailer of branded footwear, licensed and branded headwear, and a wholesaler of branded footwear. The complaint alleges that during the Class Period, defendants made false and misleading statements concerning Genesco’s business and prospects. As a result of their representations, Genesco was seen as an attractive acquisition target for Foot Locker, Inc. Foot Locker ultimately made an offer and The Finish Line, Inc. and Headwind, Inc., a wholly owned subsidiary of Finish Line, subsequently made an increased offer, based on Genesco’s purported success. When the truth about Genesco’s results began to be revealed, however, Finish Line indicated it would no longer pursue the acquisition. Then, on November 26, 2007, Genesco received a subpoena from the Office of the U.S. Attorney for the Southern District of New York seeking documents related to its merger agreement and in connection with alleged violations of federal fraud statutes. On this news, Genesco’s stock plunged to $25.44 per share on November 27, 2007, almost a 16% drop from the closing price of $30.17 on November 26, 2007, on volume of 2.4 million shares. According to the complaint, during the Class Period defendants concealed the following information, which caused their statements to be materially false and misleading: (a) the Company’s stores were not performing well and would not produce the financial results being forecast for the Company; (b) the Journeys stores were performing poorly relative to plan with big same store sales declines; and (c) these poor results would be considered adverse events to potential acquirors, leading to significant share price declines at Genesco. Plaintiff seeks to recover damages on behalf of all purchasers of Genesco common stock during the Class Period (the "Class”). The plaintiff is represented by Coughlin Stoia, which has expertise in prosecuting investor class actions and extensive experience in actions involving financial fraud. Coughlin Stoia, a 190-lawyer firm with offices in San Diego, San Francisco, Los Angeles, New York, Boca Raton, Washington, D.C., Houston and Philadelphia, is active in major litigations pending in federal and state courts throughout the United States and has taken a leading role in many important actions on behalf of defrauded investors, consumers, and companies, as well as victims of human rights violations. Coughlin Stoia lawyers have been responsible for more than $45 billion in aggregate recoveries. The Coughlin Stoia Web site (http://www.csgrr.com) has more information about the firm.

Analysen zu Genesco Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Genesco Inc. 40,42 -2,18% Genesco Inc.